C156H176N22O7S — CID 157392843
3-(1H-benzimidazol-2-yl)-1-[1-[(5-methyl-1H-indol-3-yl)methyl]piperidin-4-yl]butan-1-one;3-(1H-benzimidazol-2-yl)-1-[1-[(5-methyl-1H-indol-3-yl)methyl]piperidin-4-yl]pentan-1-one;3-(1H-benzimidazol-2-yl)-1-[1-[(5-methyl-1H-indol-3-yl)methyl]piperidin-4-yl]-4-phenylbutan-1-one;3-(1,3-benzoxazol-2-yl)-1-[1-[(5-methyl-1H-indol-3-yl)methyl]piperidin-4-yl]propan-1-one;3-(6-methyl-1H-benzimidazol-2-yl)-1-[1-[(5-methyl-1H-indol-3-yl)methyl]piperidin-4-yl]butan-1-one;1-[1-[(5-methyl-1H-indol-3-yl)methyl]azetidin-3-yl]-3-(1,3-thiazol-5-yl)propan-1-one (PubChem CID 157392843) has the molecular formula C156H176N22O7S and a molecular weight of 2503.34 g/mol. Its IUPAC name is 3-(1H-benzimidazol-2-yl)-1-[1-[(5-methyl-1H-indol-3-yl)methyl]piperidin-4-yl]butan-1-one;3-(1H-benzimidazol-2-yl)-1-[1-[(5-methyl-1H-indol-3-yl)methyl]piperidin-4-yl]pentan-1-one;3-(1H-benzimidazol-2-yl)-1-[1-[(5-methyl-1H-indol-3-yl)methyl]piperidin-4-yl]-4-phenylbutan-1-one;3-(1,3-benzoxazol-2-yl)-1-[1-[(5-methyl-1H-indol-3-yl)methyl]piperidin-4-yl]propan-1-one;3-(6-methyl-1H-benzimidazol-2-yl)-1-[1-[(5-methyl-1H-indol-3-yl)methyl]piperidin-4-yl]butan-1-one;1-[1-[(5-methyl-1H-indol-3-yl)methyl]azetidin-3-yl]-3-(1,3-thiazol-5-yl)propan-1-one.
| Compound Name | 3-(1H-benzimidazol-2-yl)-1-[1-[(5-methyl-1H-indol-3-yl)methyl]piperidin-4-yl]butan-1-one;3-(1H-benzimidazol-2-yl)-1-[1-[(5-methyl-1H-indol-3-yl)methyl]piperidin-4-yl]pentan-1-one;3-(1H-benzimidazol-2-yl)-1-[1-[(5-methyl-1H-indol-3-yl)methyl]piperidin-4-yl]-4-phenylbutan-1-one;3-(1,3-benzoxazol-2-yl)-1-[1-[(5-methyl-1H-indol-3-yl)methyl]piperidin-4-yl]propan-1-one;3-(6-methyl-1H-benzimidazol-2-yl)-1-[1-[(5-methyl-1H-indol-3-yl)methyl]piperidin-4-yl]butan-1-one;1-[1-[(5-methyl-1H-indol-3-yl)methyl]azetidin-3-yl]-3-(1,3-thiazol-5-yl)propan-1-one |
|---|---|
| PubChem CID | 157392843 |
| Molecular Formula | C156H176N22O7S |
| Molecular Weight | 2503.34 g/mol |
| Exact Mass | 2501.38 |
| IUPAC Name | 3-(1H-benzimidazol-2-yl)-1-[1-[(5-methyl-1H-indol-3-yl)methyl]piperidin-4-yl]butan-1-one;3-(1H-benzimidazol-2-yl)-1-[1-[(5-methyl-1H-indol-3-yl)methyl]piperidin-4-yl]pentan-1-one;3-(1H-benzimidazol-2-yl)-1-[1-[(5-methyl-1H-indol-3-yl)methyl]piperidin-4-yl]-4-phenylbutan-1-one;3-(1,3-benzoxazol-2-yl)-1-[1-[(5-methyl-1H-indol-3-yl)methyl]piperidin-4-yl]propan-1-one;3-(6-methyl-1H-benzimidazol-2-yl)-1-[1-[(5-methyl-1H-indol-3-yl)methyl]piperidin-4-yl]butan-1-one;1-[1-[(5-methyl-1H-indol-3-yl)methyl]azetidin-3-yl]-3-(1,3-thiazol-5-yl)propan-1-one |
| SMILES | CCC(CC(=O)C1CCN(Cc2c[nH]c3ccc(C)cc23)CC1)c1nc2ccccc2[nH]1.Cc1ccc2[nH]cc(CN3CC(C(=O)CCc4cncs4)C3)c2c1.Cc1ccc2[nH]cc(CN3CCC(C(=O)CC(C)c4nc5ccccc5[nH]4)CC3)c2c1.Cc1ccc2[nH]cc(CN3CCC(C(=O)CC(Cc4ccccc4)c4nc5ccccc5[nH]4)CC3)c2c1.Cc1ccc2[nH]cc(CN3CCC(C(=O)CCc4nc5ccccc5o4)CC3)c2c1.Cc1ccc2nc(C(C)CC(=O)C3CCN(Cc4c[nH]c5ccc(C)cc45)CC3)[nH]c2c1 |
| InChI | InChI=1S/C32H34N4O.2C27H32N4O.C26H30N4O.C25H27N3O2.C19H21N3OS/c1-22-11-12-28-27(17-22)26(20-33-28)21-36-15-13-24(14-16-36)31(37)19-25(18-23-7-3-2-4-8-23)32-34-29-9-5-6-10-30(29)35-32;1-17-4-6-23-22(12-17)21(15-28-23)16-31-10-8-20(9-11-31)26(32)14-19(3)27-29-24-7-5-18(2)13-25(24)30-27;1-3-19(27-29-24-6-4-5-7-25(24)30-27)15-26(32)20-10-12-31(13-11-20)17-21-16-28-23-9-8-18(2)14-22(21)23;1-17-7-8-22-21(13-17)20(15-27-22)16-30-11-9-19(10-12-30)25(31)14-18(2)26-28-23-5-3-4-6-24(23)29-26;1-17-6-7-21-20(14-17)19(15-26-21)16-28-12-10-18(11-13-28)23(29)8-9-25-27-22-4-2-3-5-24(22)30-25;1-13-2-4-18-17(6-13)14(7-21-18)9-22-10-15(11-22)19(23)5-3-16-8-20-12-24-16/h2-12,17,20,24-25,33H,13-16,18-19,21H2,1H3,(H,34,35);4-7,12-13,15,19-20,28H,8-11,14,16H2,1-3H3,(H,29,30);4-9,14,16,19-20,28H,3,10-13,15,17H2,1-2H3,(H,29,30);3-8,13,15,18-19,27H,9-12,14,16H2,1-2H3,(H,28,29);2-7,14-15,18,26H,8-13,16H2,1H3;2,4,6-8,12,15,21H,3,5,9-11H2,1H3 |
| InChIKey | BMFDSAFECHZTKB-UHFFFAOYSA-N |
| XLogP | 31.83 |
| TPSA | 370.24 Ų |
| H-Bond Donors | 10 |
| H-Bond Acceptors | 20 |
| Rotatable Bonds | 39 |
| Heavy Atoms | 186 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2503.34 |
| LogP ≤ 5 | 31.83 |
| H-Bond Donors ≤ 5 | 10 |
| H-Bond Acceptors ≤ 10 | 20 |